In a filing, Hinge Health Inc revealed its 10% Owner Bessemer Venture Partners X L. unloaded Company’s shares for reported $23.2 million on May 23 ’25. In the deal valued at $32.00 per share,725,066 shares were sold. As a result of this transaction, Bessemer Venture Partners X L. now holds 0 shares worth roughly $0.0.
Then, Atomico Advisors IV, Ltd. sold 2,651,103 shares, generating $84,835,296 in total proceeds. Upon selling the shares at $32.00, the 10% Owner now owns 0 shares.
Before that, Insight Holdings Group, LLC sold 1,250,000 shares. Hinge Health Inc shares valued at $40,000,000 were divested by the 10% Owner at a price of $32.00 per share. As a result of the transaction, Insight Holdings Group, LLC now holds 0 shares, worth roughly $0.0.
Citizens JMP initiated its Hinge Health Inc [HNGE] rating to a Mkt outperform in a research note published on July 14, 2025; the price target was $58. A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in mid June with a ‘”an Outperform”‘ rating. Truist began covering HNGE with “Buy” recommendation on June 16, 2025. Stifel started covering the stock on June 16, 2025. It rated HNGE as “a Buy”.
Price Performance Review of HNGE
On Monday, Hinge Health Inc [NYSE:HNGE] saw its stock jump 0.61% to $47.93. Over the last five days, the stock has gained 11.28%. Nevertheless, the stocks have risen 27.61% over the past one year.
Levels Of Support And Resistance For HNGE Stock
The 24-hour chart illustrates a support level at 46.92, which if violated will result in even more drops to 45.91. On the upside, there is a resistance level at 49.73. A further resistance level may holdings at 51.54.
The most recent change occurred on June 16, 2025 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $45 price target.
